LeMaitre Vascular, Inc. (LMAT)
81.55
-1.36
(-1.64%)
USD |
NASDAQ |
Oct 13, 16:00
81.55
0.00 (0.00%)
After-Hours: 20:00
LeMaitre Vascular Market Cap : 1.865B for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 13, 2026 | 1.865B |
| October 12, 2026 | 1.896B |
| October 09, 2026 | 1.845B |
| October 08, 2026 | 1.821B |
| October 07, 2026 | 1.813B |
| October 06, 2026 | 1.807B |
| October 05, 2026 | 1.852B |
| October 02, 2026 | 1.805B |
| October 01, 2026 | 1.834B |
| September 30, 2026 | 1.888B |
| September 29, 2026 | 1.895B |
| September 28, 2026 | 1.883B |
| September 25, 2026 | 1.864B |
| September 24, 2026 | 1.848B |
| September 23, 2026 | 1.842B |
| September 22, 2026 | 1.852B |
| September 21, 2026 | 1.811B |
| September 18, 2026 | 1.803B |
| September 17, 2026 | 1.817B |
| September 16, 2026 | 1.838B |
| September 15, 2026 | 1.835B |
| September 14, 2026 | 1.847B |
| September 11, 2026 | 1.843B |
| September 10, 2026 | 1.802B |
| September 09, 2026 | 1.817B |
| Date | Value |
|---|---|
| September 08, 2026 | 1.820B |
| September 04, 2026 | 1.845B |
| September 03, 2026 | 1.840B |
| September 02, 2026 | 1.869B |
| September 01, 2026 | 1.854B |
| August 31, 2026 | 1.836B |
| August 28, 2026 | 1.839B |
| August 27, 2026 | 1.822B |
| August 26, 2026 | 1.820B |
| August 25, 2026 | 1.806B |
| August 24, 2026 | 1.828B |
| August 21, 2026 | 1.872B |
| August 20, 2026 | 1.882B |
| August 19, 2026 | 1.918B |
| August 18, 2026 | 1.864B |
| August 17, 2026 | 1.887B |
| August 14, 2026 | 1.884B |
| August 13, 2026 | 1.873B |
| August 12, 2026 | 1.878B |
| August 11, 2026 | 1.894B |
| August 10, 2026 | 1.856B |
| August 07, 2026 | 1.862B |
| August 06, 2026 | 1.848B |
| August 05, 2026 | 1.806B |
| August 04, 2026 | 2.419B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 62.66B |
| Abbott Laboratories | 177.55B |
| AngioDynamics, Inc. | 462.43M |
| Alphatec Holdings, Inc. | 1.652B |
| AtriCure, Inc. | 2.893B |
Market Cap Related Metrics
| PE Ratio | 29.05 |
| PS Ratio | 7.374 |
| PEG Ratio | 0.7996 |
| Price to Book Value | 4.436 |
| Price to Free Cash Flow | 26.21 |
| Price | 81.55 |
| Earnings Yield | 3.44% |
| PEGY Ratio | 0.7747 |
| Operating PE Ratio | 25.03 |
| Normalized PE Ratio | 29.05 |